Lisa L. Flores

FDA investigator

Appears on 20 documents from 2012 to 2026, mostly at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

20
Documents on file
5.1
Observations per 483
2012
First seen
2026
Most recent

What they cite most

From 102 observations

Activity by year

2012: 1, 2019: 1, 2020: 1, 2021: 1, 2022: 3, 2023: 2, 2024: 4, 2025: 6, 2026: 1

Where

India 12 · Nebraska 3 · Iowa 2 · Missouri 2 · South Dakota 1

Is Lisa L. Flores coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

20 documents, newest first
FirmOpen
483 Eugia Pharma Specialities LimitedFeb 6, 2026 · Sangareddy, India
483 Hetero Labs Limited, Unit-EXSep 26, 2025 · Narasapmam Village, India
483 LUPIN LIMITEDJul 17, 2025 · Pithampur, India
483 Lupin LimitedJul 17, 2025 · Pithampur, India
483 Lupin LimitedJul 8, 2025 · Pithampur, India
483 Sun Pharmaceutical Industries LtdJun 13, 2025 · Halol, India
483 Sun Pharmaceutical Industries Ltd.Jun 2, 2025 · Halol, India

About this profile

What does Lisa L. Flores inspect?

Lisa L. Flores appears on 20 documents on file covering 18 sites, mostly in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Lisa L. Flores is dated Feb 6, 2026.